
Alibaba, HIS and Line have all previously backed KKday, an online travel experience provider with more than 5 million registered users.
SoftBank has led a $68m series D round for ShipBob through its Vision Fund 2, more than doubling the logistics company’s total equity to over $130m.
Bell Food Group and M Ventures have contributed to an initial $55m series B tranche for the cultured meat developer spun out of Maastricht University.
GV has thrown its weight behind Monte Rosa Therapeutics, which is working on biotechnology to degrade disease-driving proteins that have hitherto been considered undruggable.
Creative Biosciences has collected $88m in fresh funding from a consortium of new and existing shareholders, though Kingmed Diagnostics and Tasly did not return.
Novo and Bristol Myers-Squibb formed part of a group of new and existing backers that provided cash to Galecto, based on research from the universities of Lund and Edinburgh.
Kinnevik has led the LeFrak-backed community housing service provider’s latest round, taking its overall funding in excess of $110m.
Twitter has returned to back the social media platform that provides services in 15 Indian languages, which pushed its total funding to about $264m.
Eight Roads Ventures returned for the First Data-backed payment software developer’s series D round, announced alongside two strategic acquisitions.
Cancer drug developer Silverback has secured $211m to date from investors including BMS, Celgene and Alexandria Real Estate Equities.